|
1
|
van Vliet P: Cholesterol and late-life
cognitive decline. J Alzheimers Dis. 30 Suppl 2:S147–S162.
2012.PubMed/NCBI
|
|
2
|
Wood WG, Li L, Müller WE and Eckert GP:
Cholesterol as a causative factor in Alzheimer's disease: A
debatable hypothesis. J Neurochem. 129:559–572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anstey KJ, Lipnicki DM and Low LF:
Cholesterol as a risk factor for dementia and cognitive decline: A
systematic review of prospective studies with meta-analysis. Am J
Geriatr Psychiatry. 16:343–354. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Purnell C, Gao S, Callahan CM and Hendrie
HC: Cardiovascular risk factors and incident Alzheimer disease: A
systematic review of the literature. Alzheimer Dis Assoc Disord.
23:1–10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu X and Zheng J: Cholesterol promotes the
interaction of Alzheimer β-amyloid monomer with lipid bilayer. J
Mol Biol. 421:561–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drolle E, Gaikwad RM and Leonenko Z:
Nanoscale electrostatic domains in cholesterol-laden lipid
membranes create a target for amyloid binding. Biophys J.
103:L27–L29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di Scala C, Chahinian H, Yahi N, Garmy N
and Fantini J: Interaction of Alzheimer's β-amyloid peptides with
cholesterol: Mechanistic insights into amyloid pore formation.
Biochemistry. 53:4489–4502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McGuinness B, O'Hare J, Craig D, Bullock
R, Malouf R and Passmore P: Statins for the treatment of dementia.
Cochrane Database Syst Rev: CD007514. 2010. View Article : Google Scholar
|
|
9
|
Daugvilaite V, Arfelt KN, Benned-Jensen T,
Sailer AW and Rosenkilde MM: Oxysterol-EBI2 signaling in immune
regulation and viral infection. Eur J Immunol. 44:1904–1912. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olkkonen VM, Beaslas O and Nissilä E:
Oxysterols and their cellular effectors. Biomolecules. 2:76–103.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Björkhem I, Cedazo-Minguez A, Leoni V and
Meaney S: Oxysterols and neurodegenerative diseases. Mol Aspects
Med. 30:171–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prasanthi JR, Huls A, Thomasson S,
Thompson A, Schommer E and Ghribi O: Differential effects of
24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid
precursor protein levels and processing in human neuroblastoma
SH-SY5Y cells. Mol Neurodegener. 4:12009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang DD, Yu HL, Ma WW, Liu QR, Han J,
Wang H and Xiao R: 27-Hydroxycholesterol contributes to disruptive
effects on learning and memory by modulating cholesterol metabolism
in the rat brain. Neuroscience. 300:163–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Burkard I, Rentsch KM and von Eckardstein
A: Determination of 24S- and 27-hydroxycholesterol in plasma by
high-performance liquid chromatography-mass spectrometry. J Lipid
Res. 45:776–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karu K, Hornshaw M, Woffendin G, Bodin K,
Hamberg M, Alvelius G, Sjövall J, Turton J, Wang Y and Griffiths
WJ: Liquid chromatography-mass spectrometry utilizing multi-stage
fragmentation for the identification of oxysterols. J Lipid Res.
48:976–987. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zurkinden L, Solcà C, Vögeli IA, Vogt B,
Ackermann D, Erickson SK, Frey FJ, Sviridov D and Escher G: Effect
of Cyp27A1 gene dosage on atherosclerosis development in
ApoE-knockout mice. FASEB J. 28:1198–1209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saito Y and Noguchi N: 7-Hydroxycholestrol
as a possible biomarker of cellular lipid peroxidation: Difference
between cellular and plasma lipid peroxidation. Biochem Biophys Res
Commun. 446:741–744. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shafaati M, Olin M, Båvner A, Pettersson
H, Rozell B, Meaney S, Parini P and Björkhem I: Enhanced production
of 24S-hydroxycholesterol is not sufficient to drive liver X
receptor target genes in vivo. J Intern Med. 270:377–387. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YL, Wang LM, Chen Y, Gao JY, Marshall
C, Cai ZY, Hu G and Xiao M: Changes in astrocyte functional markers
and β-amyloid metabolism-related proteins in the early stages of
hypercholesterolemia. Neuroscience. 316:178–191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wirths O, Thelen K, Breyhan H, Luzón-Toro
B, Hoffmann KH, Falkai P, Lütjohann D and Bayer TA: Decreased
plasma cholesterol levels during aging in transgenic mouse models
of Alzheimer's disease. Exp Gerontol. 41:220–224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marwarha G and Ghribi O: Does the
oxysterol 27-hydroxycholesterol underlie Alzheimer's
disease-Parkinson's disease overlap? Exp Gerontol. 68:13–18. 2015.
View Article : Google Scholar : PubMed/NCBI
|
